Nader Francois
Director at MRNA; President, CEO and Director at NPS PHARMACEUTICALS INC
- Sold, on record
- $11.9M
- Dollars the filings state
- Form 4 sales
- 4
- Latest May 10, 2022
- Form 144 notices
- 0
- Proposed sales
- Companies
- 2
- Filed as an executive or holder
Companies
- MRNAModerna, Inc.Director
- NPS PHARMACEUTICALS INCPresident, CEO and Director
Sales by reason
Form 4 sales per month, last 12 months.
Sales by company
- NPS PHARMACEUTICALS INC661,175 shares
- MRNA3,196 shares
Shares sold, every Form 4 sale on record.
Timeline
- 1 Form 4 sale NPS PHARMACEUTICALS INCPlan not statedFeb 3, 2010 2010
Sold 19,350 shares at $3.37 ($65k)
Nader Francois, President, CEO and Director
Sold 11.4% of holdings ($570k position)149,658 shares leftFirst sale on recordFiling
- 2 Form 4 sale NPS PHARMACEUTICALS INCUnusualApr 10, 2013 +1162 days
Sold 448,367 shares at $11.32 ($5.1M)
Nader Francois, President, CEO and Director
Sold 67.3% of holdings ($7.5M position)217,478 shares leftFirst sale on recordFiling
- 3 Form 4 sale NPS PHARMACEUTICALS INCUnusualSep 27, 2013 +170 days
Sold 193,458 shares at $32.93 ($6.4M)
Nader Francois, President, CEO and Director
Sold 68.8% of holdings ($9.3M position)87,820 shares leftFiling
- 4 Form 4 sale MRNAPlan not statedMay 10, 2022 +3147 days
Sold 3,196 shares at $136.10 ($435k)
Nader Francois, Director
Sold 13.4% of holdings ($3.2M position)20,607 shares leftFirst sale on recordFiling
Every transaction
Loading transactions…
Sales and notices (4)
| Source | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| May 10, 2022 | May 12, 2022 | MRNA | Director | Form 4 sale | 3,196 | $435k | 13.4% | Plan not stated | SEC |
| Sep 27, 2013 | Sep 30, 2013 | NPS PHARMACEUTICALS INC | President, CEO and Director | Form 4 sale | 193,458 | $6.4M | 68.8% | Unusual | SEC |
| Apr 10, 2013 | Apr 10, 2013 | NPS PHARMACEUTICALS INC | President, CEO and Director | Form 4 sale | 448,367 | $5.1M | 67.3% | Unusual | SEC |
| Feb 3, 2010 | Apr 2, 2010 | NPS PHARMACEUTICALS INC | President, CEO and Director | Form 4 sale | 19,350 | $65k | 11.4% | Plan not stated | SEC |